What is it about?

This article appraises the pathological AGE-RAGE concerns in diabetes and its associated complications, mainly focusing on the phenomenon of both circulatory AGEs and those accumulating in tissues in diabetic nephropathy, diabetic neuropathy, and diabetic retinopathy, discussing the potential protective role of HMG-R inhibitors against diabetic complications.

Featured Image

Read the Original

This page is a summary of: Glycation and HMG-CoA Reductase Inhibitors: Implication in Diabetes and Associated Complications, Current Diabetes Reviews, April 2019, Bentham Science Publishers,
DOI: 10.2174/1573399814666180924113442.
You can read the full text:

Read

Contributors

The following have contributed to this page